Related Experiment Video
Updated: Feb 26, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer
Michalis V Karamouzis1, Kostas A Papavassiliou1, Christos Adamopoulos1
1Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Abstract:
The actions of estrogens are mediated by estrogen receptors, ERα and ERβ. Recent genomic landscaping of ERα- and ERβ-binding sites has revealed important distinctions regarding their transcriptional activity. ERβ and its isoforms have been correlated with endocrine treatment responsiveness in breast tumors, while post-translational modifications, receptor dimerization patterns, and subcellular localization are increasingly recognized as crucial modulators in prostate carcinogenesis. Androgen receptor (AR) is essential for the development and progression of prostate cancer as well as of certain breast cancer types. The balance between the activity of these two hormone receptors and their molecular interactions in different clinical settings is influenced by several coregulators. This comprises a dynamic regulatory network enhancing or limiting the activity of AR-directed treatments in breast and prostate tumorigenesis. In this review, we discuss the molecular background regarding the therapeutic targeting of androgen/estrogen receptor crosstalk in breast and prostate cancer.
Insights
Estrogen receptors (ERα, ERβ) and androgen receptors (AR) play key roles in breast and prostate cancers. Understanding their crosstalk is crucial for developing effective targeted therapies.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Estrogen receptors (ERα and ERβ) mediate estrogen actions, with distinct transcriptional activities.
- Estrogen receptor beta (ERβ) and its isoforms are linked to endocrine treatment response in breast tumors.
- Androgen receptor (AR) is vital for prostate and certain breast cancer progression, influenced by coregulators.
Purpose of the Study:
- To review the molecular mechanisms of androgen/estrogen receptor crosstalk.
- To discuss therapeutic targeting strategies for hormone-driven breast and prostate cancers.
Main Methods:
- Genomic landscaping of ERα and ERβ binding sites.
- Analysis of post-translational modifications, dimerization, and localization of ERβ.
- Review of coregulator influence on AR and ER activity.
Main Results:
- Genomic studies reveal differential ERα and ERβ transcriptional regulation.
- ERβ modifications and localization are critical in prostate cancer.
- Coregulators dynamically modulate AR and ER activity in tumorigenesis.
Conclusions:
- Targeting the crosstalk between androgen and estrogen receptors offers potential therapeutic avenues.
- Understanding receptor interactions is key to optimizing AR-directed treatments in breast and prostate cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Signal Transduction: Overview
Typically, signal transduction involves three...
Intracellular Hormone Receptors

